51 results
Page 2 of 3
6-K
EX-99.1
hrfmiw7a4ql9o9
9 Nov 20
ObsEva appoints Brian O’Callaghan as Chief Executive Officer
7:32am
6-K
lsgf2ukno1z0
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-99.1
ku9cil7nrk6oh
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-99.2
qsi3q
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
q72u 23l0
1 Jul 20
ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA
6:15am
6-K
EX-99.3
xvrt0lu32oeza28vdguu
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.2
kzpxi
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
ul7oa 7yk
15 Jan 20
Current report (foreign)
8:35pm
6-K
ps2no2vvd677bos
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.1
6gpob746626
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.1
qyoh9 v8c0
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
xy8lwe71nru6yq410m8
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
5lu6lbf9x2kj
9 Oct 18
Current report (foreign)
4:42pm